Uplizna
Payments companies reported to CMS as associated with Uplizna. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Uplizna, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Uplizna
These are the largest totals companies reported as associated with Uplizna. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| John Stone | Boston, MA | Rheumatology | $576,204.61 |
| Robert Sergott | Philadelphia, PA | Neuro-Ophthalmology | $278,449.30 |
| Ahmed Obeidat | Milwaukee, WI | Neurology (Psychiatry & Neurology) | $236,764.75 |
| Benjamin Osborne | Washington, DC | Neurology (Psychiatry & Neurology) | $188,811.02 |
| Aram Zabeti | Cincinnati, OH | Neurology (Psychiatry & Neurology) | $181,348.68 |
| Andrew Lee | Houston, TX | Ophthalmology | $163,198.01 |
| Mirla Avila | Lubbock, TX | Neurology (Psychiatry & Neurology) | $159,508.03 |
| Mark Tullman | Saint Louis, MO | Neurology (Psychiatry & Neurology) | $143,661.71 |
| Augusto Miravalle | Chicago, IL | Neurology (Psychiatry & Neurology) | $120,274.20 |
| Daniel Becker | Lutherville, MD | Neurology (Psychiatry & Neurology) | $120,212.88 |
Prescribed Uplizna?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.